Logo

synthetic oligonucleotides

EnPlusOne Biosciences Nabs Exclusive License to RNA Synthesis Technology from Wyss Institute

EnPlusOne Bio has secured a worldwide license to the ezRNA platform developed in the lab of George Church, one of the firm's cofounders.

GenScript, Allozymes Partner on Enzyme Discovery and Development Services

GenScript will provide mutant synthetic DNA libraries and protein expression while Allozymes will offer high-throughput screening services.

Wayfinder Biosciences Raises $3.5M in Seed Funding

The Seattle-based startup said it would use the funds to scale its RNA design platform, with a focus on expanding into therapeutics.

EnPlusOne Biosciences on Path Towards Commercial Enzymatic RNA Synthesis
Premium

The latest George Church startup says its platform technology can deliver enzymatically synthesized RNA at a commercial scale in the near future.

Enzymatic RNA Synthesis Firm EnPlusOne Biosciences Launches With $12M in Seed Funding

The Harvard spinout, cofounded by George Church, plans to synthesize and supply oligonucleotides greater than 100-nt in length with its ezRNA synthesis platform.

Aug 5, 2022

Twist Bioscience Raises Full-Year Revenue Guidance After Fiscal Q3 Revenues Rise 60 Percent

Apr 26, 2022

RootPath Brings Collaborators Into the Fold With Origami-Based Synthetic DNA Assembly Method
Premium

Apr 20, 2022

Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service
Premium

Apr 18, 2022

Startups Emerge at SynBio Conference Offering Longer, Purer Synthetic DNA
Premium

Apr 14, 2022

GenScript Jumps Into DNA Data Storage Market With New Synthesis Platform
Premium

Apr 5, 2022

Twist Bioscience, Ginkgo Bioworks Sign New Synthetic DNA Supply Agreement

Jan 28, 2022

Maravai LifeSciences Acquires Nucleotide Maker MyChem for at Least $240M

Nov 30, 2021

DNA Script Receives CE Mark for Syntax Enzymatic DNA Synthesis Platform

Nov 9, 2021

DNA Script on Track for Release of Enzymatic DNA Synthesis Platform in 2022
Premium

Nov 4, 2021

Codexis, Casdin Capital Invest $10M in Molecular Assemblies

Oct 26, 2021

DNA Script Raises $165M in Series C Funding Round

Aug 18, 2021

Researchers Call for Investment in Direct RNA Sequencing
Premium

Aug 6, 2021

Twist Bioscience Fiscal Q3 Revenues Grow 65 Percent

Jul 14, 2021

Sci-Space Method Ties Single-Cell Gene Expression Differences to Spatial Context
Premium

Jun 23, 2021

Codex DNA Closes $122.7M IPO

Apr 15, 2021

Molecular Assemblies Extends Series A Financing Round by $11.8M

Apr 12, 2021

Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings

Mar 18, 2021

DNA Script Preparing Launch of Benchtop Enzymatic Synthesizer for 'DNA on Demand'
Premium

Feb 23, 2021

DNA Script Exclusively Licenses Modified DNA Printing Technology From Baseclick

Feb 22, 2021

Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays in China

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.